PROJohnson & Johnson
stock263.73
+2.29 (+0.88%)
Price as of 13 Oct, 12:46 · Rate limit reached. Please try again in a minute.
Good Money Guide Pro Score
Neutral
Mixed investment profile
Technical Analysis
Short-Term Outlook
Neutral
2 bull · 2 bear · 1 neutral
Medium-Term Outlook
Bearish
1 bull · 3 bear · 0 neutral
Price below 50-day MA
Price above 200-day MA
Price below 12-day EMA
Price below 26-day EMA
Neutral momentum zone
MACD below signal line
Oversold — potential reversal up
Price near lower band — potential bounce
Volatility measure — informational only
Volume Indicators
On Balance Volume (OBV)
Volume Accumulation Distribution (VAD)
Market Statistics
Day Change
+2.29
Market Cap
390B
Exchange
NYSE
Fundamentals
Rate limit reached. Please try again in a minute.
Analyst Forecast
Rate limit reached. Please try again in a minute.
Fundamental Analysis
Unable to load fundamental data
Learn about Johnson & Johnson
What is Johnson & Johnson?
Johnson & Johnson is a global healthcare giant that develops medical devices, pharmaceuticals, and consumer health products. The company operates through a diversified business model, selling everything from prescription drugs and surgical tools to well-known household brands. It is one of the world's largest and most established healthcare organizations.
Is Johnson & Johnson a good investment?
JNJ is often favored by investors for its long history of dividend payments and its stable, diversified revenue streams. However, it faces risks such as ongoing legal challenges regarding its product safety and the inherent volatility of the pharmaceutical patent cycle. Please note that this information is for educational purposes only and does not constitute financial advice.
How do you invest in Johnson & Johnson?
You can invest in Johnson & Johnson by opening an account with a regulated stockbroker that offers access to the New York Stock Exchange. Once your account is funded, search for the ticker symbol 'JNJ' to buy individual shares. Alternatively, you can gain exposure to the stock through broader healthcare-focused index funds or ETFs.
Educational content generated by AI — not financial advice.
Time & Sales
No trades yet.
News & Sentiment
Rate limit reached. Please try again in a minute.
Community Discussion
No posts yet for JNJ — be the first to start the discussion.
Point & Figure Analysis
OHLC
Signals
as of 07 Oct 2026Targets
Famous Investors Holding JNJ
Source: SEC Form 13F, reporting period 30 Jun 2026. 45-day lag applies.